Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer

Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer

Jingxin Liu,1 Zhangzhen Shi,2 Yuansong Bai,2 Lin Liu,1 Kailiang Cheng11Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, People’s Republic of China; 2Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Chang...

Full description

Bibliographic Details
Main Authors:	Liu J, Shi Z, Bai Y, Liu L, Cheng K
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-05-01
Series:	Cancer Management and Research
Subjects:	SII Prognosis Immunity Inflammation Triple-negative breast cancer
Online Access:	https://www.dovepress.com/prognostic-significance-of-systemic-immune-inflammation-index-in-tripl-peer-reviewed-article-CMAR

Similar Items

Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer
by: Wang P, et al.
Published: (2019-01-01)

Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients
by: Sun Y, et al.
Published: (2019-04-01)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
by: Mirco Pistelli, et al.
Published: (2014-06-01)

Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer
by: Wang Y, et al.
Published: (2019-10-01)

TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer
by: Yunhui Li, et al.
Published: (2013-07-01)

Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis
by: Yilong Huang, et al.
Published: (2020-10-01)

Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
by: Shuang Ye, et al.
Published: (2019-05-01)

Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
by: Xiang Song, et al.
Published: (2019-09-01)

Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer
by: Yu Song, et al.
Published: (2020-06-01)

High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
by: Jiang L, et al.
Published: (2020-01-01)

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
by: Jasmin Zeindler, et al.
Published: (2019-09-01)

Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer
by: Haoyu Wang, et al.
Published: (2020-02-01)

Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
by: Ilie SM, et al.
Published: (2018-11-01)

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
by: Shristi Bhattarai, et al.
Published: (2019-07-01)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
by: Yoshimasa Kosaka, et al.
Published: (2020-02-01)

Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
by: Chen L, et al.
Published: (2017-12-01)

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
by: Tian Tian, et al.
Published: (2021-12-01)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
by: Qiang Wu, et al.
Published: (2019-10-01)

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
by: F. Piras, et al.
Published: (2011-11-01)

Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
by: Shaoquan Zheng, et al.
Published: (2020-11-01)

Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics
by: Maschenka CA. Balkenhol, et al.
Published: (2021-04-01)

Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients
by: Shi H, et al.
Published: (2019-12-01)

Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
by: Leo Phillips, et al.
Published: (2019-05-01)

The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
by: Olga O Gordeeva, et al.
Published: (2019-09-01)

Focus on Triple-Negative Breast Cancer: Potassium Channel Expression and Clinical Correlates
by: Elena Lastraioli
Published: (2020-05-01)

A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
by: Guoxuan Gao, et al.
Published: (2020-03-01)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
by: Sainan Liu, et al.
Published: (2021-05-01)

Prognosis in triple‐negative apocrine carcinomas of the breast: A population‐based study
by: Wenyu Wu, et al.
Published: (2019-12-01)

Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis
by: Qianqian Yuan, et al.
Published: (2021-03-01)

PD-L1 Protein Expression in Middle Eastern Breast Cancer Predicts Favorable Outcome in Triple-Negative Breast Cancer
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021-01-01)

Supervised Machine Learning Predictive Analytics For Triple-Negative Breast Cancer Death Outcomes
by: Xu Y, et al.
Published: (2019-11-01)

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
by: Jia Jin, et al.
Published: (2018-04-01)

Targeting the androgen receptor in triple-negative breast cancer: current perspectives
by: Mina A, et al.
Published: (2017-09-01)

Response and Long-Term Effect of Patients with Triple-Negative Breast Cancer Receiving Neo-Adjuvant Anthracycline-Based Chemotherapy
by: Zhengkui SUN, Xingtian MA, Yudong WU
Published: (2009-06-01)

Prognostic significance of adipophilin expression in biopsy specimens of patients with triple‑negative breast cancer
by: Ishida, M., et al.
Published: (2022)

Prognostic Value of Systemic Immune-Inflammation Index for Major Adverse Cardiac Events and Mortality in Severe Aortic Stenosis Patients after TAVI
by: Aydin Rodi Tosu, et al.
Published: (2021-06-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Leila Rahmani, et al.
Published: (2012-03-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Tahere Zarouk Ahimahalle, et al.
Published: (2012-01-01)